[{"Assets_0_Q2_USD":915066000.0,"CommonStockSharesOutstanding_0_Q2_shares":86847000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-6172000.0,"NetIncomeLoss_2_Q2_USD":70592000.0,"NetIncomeLoss_1_Q2_USD":116003000.0,"StockholdersEquity_0_Q2_USD":629031000.0,"EarningsPerShareBasic_1_Q2_USD":1.34,"EarningsPerShareBasic_2_Q2_USD":0.82,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":86445000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":86077000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]